Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Misleading, CANB getting ready for its next leg up. Smart Money loading and holding. Record Earnings Quarter after Quarter speaks Volumes with this Junior CBD Gem. Patience is key and understood by Majority of CANB Shareholders;)
Anyone know why VATE’s New ticker symbol BLEG can’t be located?
Thanks Sky
Excellent Tweet from CANB! Easy to see why ALL EYES focused and Accumulating....A No Brainer.
:
CANB is excited to report our revs have increased YOY with a gross margin of 79%. Our updated OS is 3 million, with a micro float of 1.4 MILLION, among the thinnest #MJ
See our latest filing here:
$CANB #CBD #Health #Food #Wellness #Cannabis
agree, bring on the higher exchange.
Agree, Expecting News soon. Higher Exchange listing possibly?
Completely Agree Sleek, CANB needed this reverse split for the Nasdaq listing.
Also I Definitely Accept the Mod Position on this Salami bd. It would be an Honor Sir.
Totally agree, grabbed some more discounted shares today as well :)
Smart Money continues to Accumulate at this discounted level. Not so easy to trick into selling any shares, sorry :)
I added also, Up from here ;)
I added this AM as well. Considering we don't know the reason for the R/S I am not classifying it as good or bad yet. Would like it to have been announced differently but I am not going to attack Ryan for it, we don't know why it was not disclosed earlier, S-1 maybe?; find out soon enough.
All the best,
Knife
Correct, Add to that Quarter after Quarter Record Earnings ;)
excellent q yesterday 7m revs 1.3m float
Misleading, Quarter after Quarter Record Earnings speaks Volumes on this Junior Gem. No wonder Smart Money keeps Loading Up at these Oversold Levels....its a No Brainer.
Disagree, not so easy to scare Smart Money from Loading Big on CANB, Quarter after Quarter Record Earnings is only the beginning for this Junior Gem. Smart Money will Buy All Day Long at these levels.
At these Prices CANB is a Steal!
Agree, these are definitely bargain prices.
Correct, Real Run has not even started yet, Best Time to Load Up is now. Smart Money will not be left behind that's for sure.
Excellent Honest Observation, Smart Money Continues to Accumulate at these Oversold Levels.....Period.
Record Earnings Quarter after Quarter alone speaks Volumes. Loading and Holding will Continue...Period.
Misleading, Best not to wait to long to get back in IMO
Smart Move, your not the only one going Long with CANB. Accumulation Continues as All Eyes focus 24/7 on this Junior Gem.
Excellent News Release!
HICKSVILLE, NY, May 19, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Can B Corp (OTCQB: CANB) (“Can B Corp” or the “Company”), a diversified health and wellness company, would like to update its shareholders on the planned launch of certain branded products under a License Agreement with LifeGuard™ Licensing Corp.
The Company is pleased to announce the completion of the 3D Design of the unique packaging of our “Skin Preserver” Sun Block line, as well as our Lip Balm line. The products are planned to launch in a value-add package with the unique and identifiable LifeGuard™ rescue buoy with lanyard rope. The Company is now moving forward to molds and manufacturing, and, with a soon to be contracted manufacturer, we will be moving quickly for the production of our initial SPF30 and SPF50 lines, as well an after-sun moisturizer. We’re currently working to finalize a manufacturer for our lip balm and lifestyle water line. Initial product renderings may be viewed at www.shoplifeguard.com.
At this point due to the uncertainty of beach openings and permissible outdoor gatherings, we are targeting a limited launch in Florida and other southern States, and will have nationwide availability online. This is planned to be followed by a National Retail launch in 2021.
Marco Alfonsi, CEO of Can B, commented, “We are very pleased with the initial product design and anticipate great response from consumers and look forward to this being a significant brand in the multi-billion-dollar Sun Protection category (quoted per Statista Research Department, Mar 15, 2018- Sun Care Products US Sales $1.8 billion USD).”
About CanB Corp.
CanB Corp is a Health & Wellness company dedicated to delivering the highest quality CBD products, nutritionals, consumer products, and related medical equipment. Products are sold to consumers online, via retailers, marketing partners, events, and through doctors and other medical and health & wellness organizations. Further, we are committed to serving our customers and marketing partners, with not only the best products, but the best service and experience in the marketplace now and in the future.
CanB Corp owns and operates a manufacturing facility under Pure Health Products in Lacey, Washington where all CBD based products are blended and packaged. CanB Corp owns and operates Duramed Inc, which sells medical supplies and devices. CanB Corp owns and operates NY Hemp Depot and Green Grow Farms, which are licensed to grow and cultivate Hemp in the State of New York.
For more information about CanB Corp., please visit: Canbiola.com Coming soon www.CanBCorp.com
Forward-Looking Statements
Forward-looking statements and risks and uncertainties discussed in this letter contain forward-looking statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape or manner of our future financial condition or stock price.
Follow Canbiola on:
Twitter @CanbiolaHealth
Instagram @canbiola.inc or @canbiola_cbd or @canbiola_medical_cbd
Facebook
Investors and Media:
IR@canbiola.com
(646) 397-2309
Correct, the breakout is about to begin, loaded and buying more CANB Golden Shares.
These small dips will be hit with Buys, A No Brainer to Load Up at these Oversold Levels :)
Spot On BG, Excellent CANB Update! Just Can't Fool Smart Money...Accumulation Continues with this Undervalued GEM. Get in Now or Chase Later....Period.
***Awesome CANB update***
CANB is going to shock everyone very soon! Mitch will get CBD isolates legalized.
Vision vision VISION!
READ:
GlobeNewswire
Intrado Logo
Search
REGISTER
SIGN IN
ENGLISH
FRANÇAIS
CONTACT US
GLOBAL DISTRIBUTION
NEWSWIRE SERVICES
REGULATORY FILINGS
MEDIA PARTNERS
CANB.png
Pure Health Products LLC Update -- Phase I Complete of Production Upgrades/Super Food Production Online
May 14, 2020 09:00 ET | Source: Can B Corp
HICKSVILLE, NY, May 14, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Can B Corp (OTCQB: CANB) (“Can B Corp” or the “Company”), a diversified health and wellness company, would like to update shareholders on the Pure Heath Products LLC (“PHP”) Division, a wholly-owned subsidiary of Can B Corp located in Lacey, Washington. PHP is an innovator in the formulation and manufacturing of hemp-derived CBD products containing no THC. PHP’s formulation and manufacturing directly serve our full line of products including tinctures, salves, and gels, as well as a private label service for independent consumer brands.
The Company is pleased to announce it has experienced limited interruption during this challenging COVID-19 pandemic. In accordance with applicable federal and state guidelines, the Company has implemented and prioritized strict social distancing measures, good manufacturing practices, proper sanitization measures, and new manufacturing guidelines. Although several Company customers have experienced business shutdowns during the last few weeks, we are pleased to announce many have resumed business via online ordering and/or initiating new direct shipment orders. Additionally, the Company has recently installed new state-of-the-art, high-speed, automatic bottling and capping equipment and new bulk processing equipment for the production of the Can B Superfood line, which is now available at www.CanBSuperFood.com. This line allows for full in-house formulation and production for our high-quality Superfoods.
We are also pleased to announce that with our new equipment installations, Phase One of upgrading the manufacturing capacity to triple the current capacity is complete. Phase Two is well underway. Phase Two will allow the PHP facility to become GMP compliant and pave the way for an anticipated growth as the country evolves from this COVID-19 pandemic crisis. Phase Two will also encompass the planned vertical integration of PHP as we have just received our second batch of pure isolate from our very own hemp production, Green Grow Farms, which will sustain our production and sales for the months to come.
PHP President Pat Ferro commented, “In spite of the challenges thrust upon us during the pandemic crisis, our team of dedicated research and development specialists have forged ahead with the new product development schedule in-tact and new formulas fully vetted for our Can B superfood lines.” Pat continued, “And I have challenged the Can B Corp sales staff to take on all the business they can sell because we are primed and ready to meet all sales targets.”
About Can B Corp.
Can B Corp is a health and wellness company dedicated to delivering the highest quality CBD products, consumer products, and related medical equipment. Products are sold to consumers online, via retailers, marketing partners, events, and through doctors and other medical and health and wellness organizations. Our products are designed, grown, and produced to the highest industry standards. Further, we are committed to serving our customers and marketing partners with not only the best products but the best service and experience in the marketplace, now and in the future.
Can B Corp owns and operates a manufacturing facility under Pure Health Products in Lacey, Washington where all CBD based products are blended and packaged. Can B Corp owns and operates Duramed, Inc., which sells medical supplies and devices. Can B Corp owns and operates NY Hemp Depot and Green Grow Farms, which are licensed to grow and cultivate Hemp in the State of New York.
About Pure Health Products
Pure Health Products, LLC is a leader in the formulation and manufacturing of hemp-derived CBD products. Our team of formulators and chemists have been pioneers and innovators contributing to the evolution of the hemp industry.
We are exacting in our process and adhere to all GMP and ISO 9001 standards. We respect the principle that garbage in equals garbage out. It is with this in mind that we source, grow, and utilize the finest ingredients and process to ensure the best results.
In our state-of-the-art facility, we can private label our existing line of products for your company, or our formulators can custom formulate products designed to address your target market and the goals of your company.
For more information about Can B Corp., please visit: Canbiola.com or www.CanBCorp.com
Forward-Looking Statements
Forward-looking statements and risks and uncertainties discussed in this letter contain forward-looking statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape, or manner of our future financial condition or stock price.
Follow Canbiola on:
Twitter @CanbiolaHealth
Instagram @canbiola.inc or @canbiola_cbd or @canbiola_medical_cbd
Facebook
Investors and Media:
IR@canbiola.com
(646) 397-2309
The Badguy
Impressive Info on the New FDA Comissioner, Thank You!
This is our new FDA Commissioner
Dr. Stephen Hahn was confirmed by the Senate on December 12, 2019
While you are watching this 2 minute video, keep in mind that this is Congress’ partner in unchaining CBD in 2020 via legalization and enforcement discretion:
Correct, CANB NASDAQ bound. Smart Investors will not so easily be fooled into selling, especially at these Oversold Levels. All Eyes focused 24/7 on CANB.
:
CANB After structuring to a 1.3M share float they have assembled a BoD with the capacity to drive revenue, expand product line and a cap table which better suits institutional investors and a listing on a National Exchange. https://canbiola.com https://pureleafoil.com #CBD
Looks like Smart Investors have Done their Research and Agree Why Smart Money Likes CANB. Thanks Sleek for pointing out the Facts.
WHY I LIKE CANB
As the only publicly traded company in America producing and selling a full lineup of Pure CBD Oil products, as well as growing and processing hemp for CBD Isolate, CANB is best positioned to deliver a windfall to its investors in 2020 due to the FDA/Congress permitting Pure CBD in dietary supplements to sell nationally
Mile High Labs and Medterra are two of the biggest CBD Isolate and Pure CBD product companies in America and both are wildly successful, but neither one is publicly traded, so where else can an investor gain exposure to CBD Isolate and Pure CBD products besides CANB?
Being the only CBD Oil stock in America utilizing the formulation of CBD most likely to be permitted to sell nationally by the FDA/Congress is certainly the most obvious advantage that CANB has over the rest of the sector:
Congress’ Take — Only Pure CBD Oil (CBD Isolate) Products Will Be Legalized By HR 5587:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155119858
CANB IS THE ONLY PURE CBD OIL STOCK IN AMERICA:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155341143
The FDA’s Take — Why Pure CBD Oil will be the ONLY formulation permitted to sell nationally:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154667646
But there are several other advantages that CANB possesses, and the following favorable factors are acting synergistically with CANB’s Pure CBD formulation to give it the greatest % gain potential from current prices in the CBD Oil sector:
1. Most rapid annual revenue growth in the sector
345% revenue growth year-over-year with 74% gross margins:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154830145
2. The depth and expertise of the corporate and medical advisory boards
8 MDs, 4 attorneys, 1 orthopedic surgeon and a Senator
https://canbiola.com/management-team/
3. Processor of raw hemp into CBD Isolate (as opposed to Full Spectrum CBD)
That is a unique advantage because CBD Isolate Processing is a huge market, there’s a tremendous lack of processors, and as has already been stated, Pure CBD is likely to be the only formulation to receive FDA approval for national sales
CANB is partnering with Mile High Labs for processing hemp — https://www.milehighlabs.com/
Canbiola Becomes Vertically Integrated with its Joint Venture with NY SHI and Shi Farms
https://www.globenewswire.com/news-release/2019/07/22/1885849/0/en/Canbiola-Becomes-Vertically-Integrated-with-its-Joint-Venture-with-NY-SHI-and-Shi-Farms.html
4. Complete vertical integration from seed to sale
CANB is also a grower of hemp as well, so they have achieved complete vertical integration and full control over the entire supply chain from seed to sale, thereby maximizing profit margins
CANB is partnering with Shi Farms for growing hemp
https://www.shifarms.com/
CANB Growing & Processing Hemp In 4 States — CO, NY, TX, TN
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152847539
CANB Processing Hemp With Mile High Labs As Partner — Processing is biggest growth area in Hemp/CBD industry in 2020:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153362683
Hemp Processing Pics & Vids:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153362807
5. Medical Sales
CANB sells to both the retail and medical markets, but they specialize in the sales of CBD Oil products to the medical & healthcare community, which is a far less crowded market than retail
6. 2019 Accomplishments and Growth Plans For 2020:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153336437
www.canbcorp.com/brands/
7. CANB Moving into CBD Foods and Beverages
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153594436
8. Potential to uplist to Nasdaq
Canbiola, Inc. (the “Company”) submitted an application to be listed on The Nasdaq Capital Market® on June 4, 2019. The Company intends to diligently pursue its application in order to have its securities listed on the Nasdaq Stock Market.
With an independent board of directors and the shareholder equity criteria now met, CANB now has the potential to uplist to the Nasdaq in 2020
Sleek
More like don't be the last one on the Sideline when the Run Starts.
Smart Money Loading...Period.
Good to see Smart Money loading up.
Spot On, Completely Undervalued, CANB is the real deal, Record Earnings, Quarter after Quarter. So much for the doom and gloom false info. Accumulation Continues by Smart Money, especially at these Oversold Levels :)
Misleading, CANB is the real deal, Record Earnings, Quarter after Quarter. So much for the doom and gloom false info. Accumulation Continues by Smart Money, especially at these Oversold Levels :)
Did the same, grabbed a few more shares as well :)
Excellent CANB Status Update from the company. Onward and looking forward to Continued Record Growth. Love this part of the Update:
As our country, state, counties, and towns begin to reopen, our Company will provide updates on all of our operating divisions. The company remains vigilant, committed to success, and motivated to deliver shareholder value. CEO Marco Alfonsi commented, “I want to thank all of our employees, vendors, and shareholders for the patience and support shown during these difficult times. I remain optimistic and undeterred that we will put forward another record year of growth. I believe in our company and our people. We continue to work every day and look forward to having everyone back in the saddle as soon as possible. Please know that we are here for our customers and committed to continued progress and success.”
Extremely Reassuring, just a matter of time.
Impressive, Thank You!
Excellent Links and information, Thank You! Nasdaq Bound.
FDA ENFORCEMENT DISCRETION FOR PURE CBD PRODUCTS ONLY
As the only publicly traded company in America growing and processing hemp for CBD Isolate and selling a full lineup of Pure CBD Oil products using terpenes to create the entourage effect, CANB is best positioned to deliver a windfall to its investors due to the FDA permitting the national sales of Pure CBD products only
Mile High Labs and Medterra are two of the biggest CBD Isolate processors and Pure CBD Oil products companies in America and both are wildly successful, but neither one is publicly traded, so where else can an investor gain exposure to a fully vertically integrated Pure CBD Oil product company besides CANB?
This is why CANB is a great stock to own before the FDA signals a policy of Enforcement Discretion for Pure CBD products
Here is a closer look at what Enforcement Discretion for Pure CBD products would mean for these products:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152570004
Now getting back to the question of CBD formulation and the difference between Pure CBD products, Full Spectrum CBD products and Broad Spectrum CBD products
When people say “CBD” and think about OTC products, there are 3 possible options that come to mind in terms of formulation
Before we talk about the different formulations, please understand that Hemp contains many different cannabinoids
Some say 50, others say 75, 100 or even 150+
We are only going to talk about the top 5 cannabinoids that show up in laboratory tests of hemp:
CBD
THC
CBG/CBN/CBC
Now, getting back to the most important topic of all — CBD formulations
A company has 3 basic options when it manufactures products containing CBD
1ST OPTION: “PURE CBD” OR “CBD ISOLATE”
1 CANNABINOID
CBD is CBD, right
It is often referred to as CBD Isolate
Isolate meaning the CBD is isolated from the other cannabinoids
There is Pure CBD and nothing else
A variety of different oils and fluids are typically used as solvents
Terpenes are federally legal and can be utilized to create the entourage effect
2ND OPTION: “FULL SPECTRUM CBD” OR “FULL SPECTRUM HEMP EXTRACT”
5 CANNABINOIDS
This is CBD + THC + CBG/CBN/CBC
There is no isolation or purification of the CBD here
CBD exists in its native form alongside 4 other cannabinoids (there are many more cannabinoids actually present, these are just the top 5 by concentration)
A variety of different oils and fluids are typically used as solvents
3RD OPTION: “BROAD SPECTRUM CBD”
4 CANNABINOIDS
This is CBD + CBG/CBN/CBC
The THC has been removed
In order to make this formulation, CBD is first isolated from everything else
After the THC has been removed, the CBD Isolate is then mixed back in with CBG/CBN/CBC
A variety of different oils and fluids are typically used as solvents
With this background information in mind, please feel free to read why I believe the FDA will choose Pure CBD (CBD Isolate) as the first CBD formulation to obtain federal permission to be placed into the food supply and dietary supplements, published on July 25th:
AN FDA-CENTRIC CANNABINOID-BASED PARADIGM FOR CBD PRODUCT REGULATION
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150123700
Hard evidence supporting this Pure CBD thesis began pouring in shortly thereafter
On July 30th Dr. Gottlieb wrote a piece in the Washington Post which strongly suggested that Purified CBD will become the 1st CBD formulation permitted by the FDA:
PROOF THAT THE FDA WILL APPROVE CANB’S CBD OIL PRODUCTS
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150292900
On August 9th, Dr. Gottlieb appeared on CNBC and added to the evidence that Pure CBD will receive the green light from the FDA:
CNBC VIDEO: PURIFIED CBD WILL BE FEDERALLY PERMITTED BY FDA
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150438663
If you only have 15 seconds of time, watch Dr. Gottlieb rule out THC in CBD products right here:
Spot On Sleek...Again. No wonder Smart Money is holding all their shares and Accumulating when ever possible.
Let me repeat that because of its importance
The FDA views Pure CBD products as being generally safe for public consumption at low doses and low concentrations with proper labeling and no health claims, if they are adhering to typical regulations that ensure safety such as GMPs and lab testing for impurities and contaminants
However, the FDA views THC-containing Full Spectrum CBD products as being unsafe for public consumption
In terms of THC-Free Broad Spectrum products — CBG/CBN/CBC + CBD — all we have right now is a big question mark
The safety research on the other cannabinoids present in Hemp, like CBG/CBN/CBC, is practically non-existent
So nobody knows with any scientific certainty whether or not it’s safe to allow these cannabinoids in CBD products
Moreover, the pharmaceutical industry’s interest in researching CBG/CBN/CBC is growing rapidly — they do want to explore the possibility of creating prescription pharmaceuticals out of these cannabinoids — and the FDA wants to make their exception of allowing a cannabinoid, CBD, to be sold as both a pharmaceutical drug and an OTC product a one-time exception
So the FDA has 2 reasons to keep Broad Spectrum products off the market — no safety data and preserving incentives for pharmaceutical drug development
In summary, all signs point to the FDA only giving the green light to Pure CBD products
CBD products containing THC are at risk of the FDA condemning them to be sold only intrastate, just like THC-containing MJ products — though the former products are sold in all types of stores, whereas MJ products are strictly limited to dispensaries, so there will still remain a huge difference in the investability and market size of THC-containing Hemp-derived CBD products (better and larger) in comparison to THC-containing MJ products
CBD products containing CBG/CBN/CBC are also at risk of the FDA condemning them to be sold only intrastate as well
Now I’m not saying this will always be the case for Full Spectrum and Broad Spectrum CBD products
Future Congressional legislation explicitly legalizing all Hemp-derived products, including those containing THC and CBG/CBN/CBC can render the FDA’s viewpoint and thought process virtually irrelevant
But right now, as we all await the FDA’s interim regulatory framework and/or enforcement discretion strategy for the CBD industry, the only thing that matters is which specific formulation the FDA will render safe for public consumption, federal “legalization” and national sales
All of CANB’s CBD Oil products are made from Pure CBD
CANB remains the only Pure CBD Oil stock in America
Therefore, CANB is the only stock in America producing and selling a full lineup of CBD Oil products that can attain FDA approval for national sales
Sleek
Excellent Factual Information Sleek, thank You! Easy to see why it’s so hard to pull away from CANB. Eyes are focused 24/7 Daily at these discounted prices. Accumulation Continues by Smart Money :)
:
Breadcrumb #8: Jonathan Miller April 8th 2020 Jonathan Miller announces that there will be a strong push to include CBD Legalization in Foods/Beverages/Supplements as well as Hemp Banking in the Phase Four Covid-19 Economic Stimulus Bill 12:30-17:10 provides the most important information and is well worth a listen From 15:15-15:53, Mr. Miller states the real crux of this situation: “FDA relief for our industry directly deals with the economic recovery from this Covid-19 crisis. If we can get FDA relief, it will unleash the CBD business, allow for sales of many more products without this cloud, we think the big box stores will allow these sales. We think Cola companies and other big food companies will want to put CBD in their products, which most importantly creates new markets for hemp farmers. We are really hopeful that Congress will agree that this is part of the economic recovery and that they will have an amendment to the Stimulus Four package to require the FDA to regulate CBD and to unleash this industry and the economic boost to the economy that would happen.” https://www.facebook.com/2043552242529673/videos/517338882233397/ All 9 breadcrumbs leading up to Why Hemp Banking and CBD Legalization Will Pass In Phase Four Covid-19 Economic Stimulus/Infrastructure Bill: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155282971 Sleek
Excellent Information, easy to see why CANB followers are here 24/7.
Correct BG, Smart Money Loading and Holding.
Spot On, normal morning dip before Rip. Adding and Loading. Accumulation Continues by Smart Money...Period.
:
its not dilution. they are not interested in diluting. this is a dip. may rip later or tomorrow. patience.
mm patent news this sees over $1
distributor news sees over .75 imo
many avenues of blockbuster news with this
Holding till Dollar Land....easily.